U.S. Retail REITs Stock News

Eos Energy Enterprises secured a contract with the U.S. Department of War to deploy its American-made Z3 zinc-based long-duration energy storage technology. The project will support the Golden Dome for America national defense initiative focused on grid resilience and critical infrastructure. The agreement places Eos technology within U.S. defense and energy supply chains under a government-backed program. Eos Energy Enterprises, listed as NasdaqCM:EOSE, is moving into a new arena with this...

Enova International (ENVA) has seen a series of governance updates in July, including director resignations, a new board appointment and fresh committee responsibilities, putting board composition in focus for shareholders. See our latest analysis for Enova International. Enova International’s recent boardroom changes come at a time when momentum in the stock has been strong, with a 30 day share price return of 24.58% and a year to date share price return of 45.51%. The 1 year total...

Columbia Threadneedle, part of Ameriprise Financial, has launched new actively managed ETFs focused on premium income and derivative income strategies. Johnson Stivender Wealth Advisors, a large advisory team previously at Raymond James, has joined the Ameriprise Financial platform. Ameriprise Financial (NYSE:AMP) is adding fresh product options and more advisor capacity at the same time, giving investors and clients additional ways to access its platform. The stock recently closed at...

Benchmark’s recent upgrade of Hut 8 (HUT) has drawn fresh attention to the stock, after the company reported very large year over year revenue growth and signed long term A.I. focused data center leases. See our latest analysis for Hut 8. Despite the Benchmark upgrade and new A.I. data center leases, Hut 8’s 30-day share price return is down 14.27%, while the 90-day share price return is 45.28% and the year-to-date share price return is 100.96%. Over the past year, total shareholder return is...

Earlier this week, Gold.com’s latest trading session saw it outperform the broader market as investors focused on its upcoming financial results and analyst expectations for a significantly higher year-on-year EPS. What stands out is that analyst EPS estimates have remained stable over the past month, suggesting expectations were already calibrated before this recent attention on the company’s earnings outlook. Now we’ll examine how the recent inflation-driven surge in gold prices may...

In early July 2026, Dynatrace was again named a Leader in the Gartner Magic Quadrant for Observability Platforms for the 16th consecutive time, reinforcing its role in end-to-end observability for complex AI-powered infrastructures. This long-running recognition, alongside its push toward higher government security standards such as FedRAMP High, underscores how deeply embedded Dynatrace’s platform has become in highly regulated, data-sensitive environments. We’ll now examine how Dynatrace’s...

Open Text stock is coming off a multiyear stretch of weak returns, yet its valuation checks suggest the shares may now sit on the inexpensive side of the ledger. Over the past 5 years, Open Text shareholders have seen the stock decline 47.9%, which raises the question of whether sentiment has become too pessimistic relative to the underlying business. The company is working to embed AI across its enterprise software platform and integrate past acquisitions, which can support revenue and...

Cooling inflation and reduced expectations for near term rate hikes have shifted attention back to large financial stocks that may be better positioned for stable economic conditions and moderate interest rate moves. With June CPI at 3.5% and core inflation at 2.6%, traders now see a lower probability of aggressive Federal Reserve action, which can influence how investors think about banks, insurers, and diversified financial companies. This article highlights 3 stocks from the Financial...

T1 Energy recently announced a major renewable infrastructure expansion plan, aiming to scale its solar and battery-related capabilities across core markets. This push to build out infrastructure comes as the company continues to operate with negative margins and substantial losses, keeping interest firmly in higher-risk, speculative territory. Next, we'll examine how this renewed infrastructure build-out could influence T1 Energy's existing investment narrative and future...

Upwork (UPWK) released its second annual Future Workforce Index 2026, highlighting that the share of skilled U.S. knowledge workers freelancing rose from 28% to 38% in one year, as AI-driven roles like “AI Orchestrators” gain traction. See our latest analysis for Upwork. For investors, the Future Workforce Index arrives as Upwork’s share price sits at US$9.24, with a 7 day share price return of 7.94% and a 30 day share price return of 8.96%. The year to date share price return is down 53.43%...

FDA accepts BioMarin Pharmaceutical's supplemental New Drug Application for VOXZOGO for children with achondroplasia. Submission is based on extensive long-term safety and efficacy data from VOXZOGO treatment. The filing aims to convert VOXZOGO's existing authorization into full approval and address a major post marketing requirement. For BioMarin Pharmaceutical (NasdaqGS:BMRN), the FDA's acceptance of the VOXZOGO sNDA centers attention on its rare disease focus and its role in...

Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) value has fallen 11% in the last week, but insiders who sold US$2.8m worth...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Cars.com Inc. ( NYSE:CARS ), is not the largest company out there, but it received a lot of attention from a...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Spotify Technology (SPOT) has drawn fresh investor attention after introducing transparency tools that flag whether tracks are human-made or use generative AI, while also expanding efforts to remove low-quality AI-generated content. See our latest analysis for Spotify Technology. Recent feature launches, including Spotify Technology's conversational interface and parent-managed accounts, arrive as momentum has cooled. The share price is down 15.6% year to date and the 1-year total shareholder...

La-Z-Boy (LZB) is rolling out an upgraded 3D Cloud platform that gives shoppers photorealistic views of every furniture configuration while reducing manual rendering work, a move that directly affects how the stock’s story relates to digital execution. See our latest analysis for La-Z-Boy. The 3D Cloud rollout lands at a time when La-Z-Boy’s 1-day share price return of 3.5% to $39.93 feeds into a 90-day share price return of 17.1%. The 3-year total shareholder return of 36.4% points to...

Quantum computing stocks sit at the crossroads of advanced research and real world problem solving, which can appeal to investors looking for growth stories not solely tied to traditional interest rate or inflation trends. While global data show moderating inflation in several regions and mixed growth signals across developed and emerging markets, capital continues to search for technologies that may reshape areas like logistics, materials science, and security. This Quantum Computing Stocks...

AbbVie stock has returned 150.7% over the past five years, yet its current checks present a split picture, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to significant upside while market based multiples lean the other way. A 150.7% return over five years signals that AbbVie has already rewarded long term holders, which can make fresh valuation calls more sensitive to what happens next. On the upside, expectations around continued contributions from key...

Earlier this month, Vera Therapeutics received FDA accelerated approval for TRUTAKNA (atacicept-vymj) to reduce proteinuria in adults with primary IgA nephropathy at risk for disease progression, based on interim Phase 3 data from the ongoing ORIGIN 3 trial. The approval makes TRUTAKNA the first therapy to target both BAFF and APRIL in IgA nephropathy, offering a differentiated mechanism via a once-weekly, self-administered autoinjector and underscoring Vera’s growing regulatory and...

US trade policy is back in the spotlight, with fresh signals on Section 301 tariffs for Brazil, a new trade surplus with Switzerland, and renewed scrutiny on China, especially around rare earths. That mix can reshape export flows, input costs, and pricing power for US industrials. For investors, it can mean fresh risks for some companies and potential tailwinds for others that are aligned with shifting trade routes. This article looks at 3 stocks from a US Export-Oriented Industrials screener...

On 14 July 2026, Arteris, Inc. reported that Arm is expanding its use of Arteris’ Cycuity Radix hardware security assurance technology across additional next‑generation CPU development programs to strengthen early-stage security verification and vulnerability mitigation. This deeper integration of Cycuity Radix into Arm’s design flow highlights Arteris’ growing role in addressing hardware security risks earlier in the silicon lifecycle. Next, we’ll examine how Arm’s broader integration of...

Nike, NYSE:NKE, is reportedly at risk of being removed from the Dow Jones Industrial Average, raising questions about its role in a key U.S. equity benchmark. The company is shifting away from a digital first playbook, putting more emphasis back on traditional retail partners and wholesale distribution. These changes follow reported declines in Direct and Nike Digital sales and arrive alongside broader adjustments to the business model. Nike enters this period of change with its share price...

Shopify (SHOP) is back in focus after DoorDash announced a direct integration that lets US brick and mortar Shopify retailers plug into its delivery marketplace through a native sales channel and simplified onboarding. See our latest analysis for Shopify. That integration comes as Shopify’s share price sits at US$123.55, with a 7 day share price return of 3.63% and a 30 day share price return of 9.83% after a tougher year to date. The 3 year total shareholder return of 81.08% contrasts with a...